Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian

Phase 2/3 Completed 188 enrolled PT Bio Farma Indonesia University · collab

NaSingle-groupOpen-labelPrevention

Summary

Vi-DT Typhoid vaccine is a novel vaccine. This study will be done to know the long-term protection and persistent antibody by measured the antibody titer after 2,3,4 and 5 years after immunization.

Timeline

Start: 2021-05-03
Primary completion: 2024-10-28
Completion: 2024-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vi-DT Typhoid Conjugate Vaccine	Vaccine	0.5 ml	Intramuscular

Indications

No indication recorded.